AGNC Investment Corp. Operating Cash Flow increased by 202.3% to $387.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 101.6%, from $192.00M to $387.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -19.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $344.00M | $393.00M | $376.00M | $371.00M | $322.00M | $226.00M | $94.00M | $26.00M | -$61.00M | -$52.00M | -$31.00M | $20.00M | -$20.00M | $7.00M | $79.00M | $192.00M | $180.00M | $153.00M | $128.00M | $387.00M |
| QoQ Change | — | +14.2% | -4.3% | -1.3% | -13.2% | -29.8% | -58.4% | -72.3% | -334.6% | +14.8% | +40.4% | +164.5% | -200.0% | +135.0% | >999% | +143.0% | -6.3% | -15.0% | -16.3% | +202.3% |
| YoY Change | — | — | — | — | -6.4% | -42.5% | -75.0% | -93.0% | -118.9% | -123.0% | -133.0% | -23.1% | +67.2% | +113.5% | +354.8% | +860.0% | >999% | >999% | +62.0% | +101.6% |